AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25616607
Drug: Reverse therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reverse therapy (active azithromycin if first treated with active doxycycline)
Trial: 8496526
Drug: Active medications
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active medications (overall)
Trial: 2967183
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bisoprolol (B)
Trial: 31245006
Drug: Low-dose behavioral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose behavioral treatment (8 sessions)
Trial: 8455424
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa (3 million units, three times weekly)
Trial: 8455424
Drug: Prednisolone withdrawal
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone withdrawal followed by interferon alfa (3 million units, three times weekly)
Trial: 8455424
Drug: Spontaneous normalization
RxNorm normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spontaneous normalization without treatment
Trial: 8147337
Drug: Counseling to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counseling to increase dietary calcium through food consumption to 1500 mg/d (n = 106)
Trial: 8817136
Drug: Non buffered
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non buffered crystalloid cardioplegia enriched with glutamate and mannitol (Menasché's solution)
Trial: 9489592
Drug: Troglitazone 400
RxNorm normalized name: troglitazone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 400 mg with cholestyramine 12 g
Trial: 26385341
Drug: Erythrosine dose
RxNorm normalized name: erythrosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythrosine dose of 220 μM
Trial: 30053967
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 100 [200]/25 μg
Trial: 6135344
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers (timolol)
Trial: 16047874
Drug: Sodium sulfacetamide
RxNorm normalized name: sodium sulfacetamide
DrugBank: Sulfacetamide (DB00634)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium sulfacetamide 10% and sulfur 5% cream with sunscreens
Trial: 7516297
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine
Trial: 10571797
Drug: losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan 50 mg q.d.
Trial: 10571797
Drug: losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan 50 mg plus hydrochlorothiazide (HCTZ) 50 mg q.d.
Trial: 10571797
Drug: HCTZ 50
RxNorm normalized name: HCTZ 50 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 50 mg q.d.
Trial: 8927679
Drug: Low haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low haloperidol plasma level (2 ng/mL)
Trial: 8927679
Drug: Moderate haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate haloperidol plasma level (10 ng/mL)
Trial: 8927679
Drug: Low haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low haloperidol plasma level (2 ng/mL) followed by moderate (10 ng/mL)
Trial: 8927679
Drug: Moderate haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate haloperidol plasma level (10 ng/mL) followed by low (2 ng/mL)
Trial: 19321576
Drug: Multi-micronutrient-fortified biscuits
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-micronutrient-fortified biscuits (including iron 6 mg, zinc 5.6 mg, iodine 35 microg, vitamin A 300 microg retinol equivalents) given 5 days/week for 4 months
Trial: 10686218
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oestradiol (TE10; n = 7)
Trial: 10686218
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oestradiol (TE20; n = 8)
Trial: 7194395
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of 60 ml/kg per day
Trial: 24368552
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3,000 mg × day(‐1) for 3 weeks)
Trial: 3882308
Drug: Ibuprofen 10
RxNorm normalized name: ibuprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 10 mg/kg
Trial: 23458227
Drug: Fentanyl pectin
RxNorm normalized name: Pectin
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl pectin nasal spray (FPNS) 100 μg under Rhinitis condition (symptomatic without decongestant)
Trial: 23458227
Drug: Fentanyl pectin
RxNorm normalized name: Pectin
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl pectin nasal spray (FPNS) 100 μg under Treated condition (symptomatic with oxymetazoline)
Trial: 28286047
Drug: Acetazolamide (ACTZ)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (ACTZ) 500 mg
Trial: 10102953
Drug: Prednisolone 20
RxNorm normalized name: prednisolone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 20 mg/day
Trial: 9012900
Drug: Therapeutic inhalation
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic inhalation of nitric oxide (NO)
Trial: 24937018
Drug: Iyengar yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iyengar yoga (twice weekly)
Trial: 8895944
Drug: Three-week open
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-week open oral treatment with 25 mg doxepin daily
Trial: 7759676
Drug: Structured therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured therapy with treatment manuals and monitoring
Trial: 11757831
Drug: Nasal mupirocin
RxNorm normalized name: mupirocin Nasal Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal mupirocin ointment
Trial: 22302704
Drug: Positive control
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive control (inoculated with NDV without treatment)
Trial: 12761422
Drug: Cefadroxil prophylaxis
RxNorm normalized name: Cefadroxil
DrugBank: Cefadroxil (DB01140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefadroxil prophylaxis at 12.5-15.0 mg/kg at bedtime every alternate night (group II, n=18)
Trial: 12848629
Drug: 9-month treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 9-month treatment
Trial: 12575474
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of citalopram
Trial: 28624696
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration of trastuzumab and taxane chemotherapy
Trial: 22115823
Drug: Sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine 0.4 mg
Trial: 22914584
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of hepatitis B vaccine (administered to children with anti-HBs <10 mIU/mL)
Trial: 22914584
Drug: Primary immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary immunization with recombinant hepatitis B vaccine
Trial: 24359044
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of intravenous dexketoprofen trometamol via slow i.v. infusion (Group I)
Trial: 22746387
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (MMC) monotherapy
Trial: 24718568
Drug: Conventional arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional arm (no monitoring, no drug or dose changes)
Trial: 17518172
Drug: Bolus doses
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus doses of fentanyl
Trial: 21242788
Drug: Initial trophic
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial trophic enteral nutrition (10 mL/hr)
Trial: 16873343
Drug: Nabilone 2
RxNorm normalized name: nabilone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone 2 mg
Trial: 340140
Drug: Antacid plus
RxNorm normalized name: Antacid Plus
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid plus antispasmodic combination tablets (240 mg dried aluminium hydroxide, 144 mg magnesium hydroxide, 5 mg dicyclomine hydrochloride)
Trial: 28296682
Drug: Anticipated death
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticipated death (withdrawal or withholding of treatment or brain death)
Trial: 28026912
Drug: gemigliptin 50
RxNorm normalized name: gemigliptin
DrugBank: Gemigliptin (DB12412)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemigliptin 50 mg once daily
Trial: 17291170
Drug: Internet-only treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-only treatment
Trial: 9072981
Drug: Inspiratory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory muscle training (IMT) at 30% of peak maximal inspiratory pressure (PI,max) for 30 min daily, 6 days a week for 10 weeks
Trial: 9072981
Drug: Inspiratory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory muscle training (IMT) at 10% of peak maximal inspiratory pressure (PI,max) for 30 min daily, 6 days a week for 10 weeks
Trial: 12888872
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH, intravenous, aPTT-adjusted for 5 to 8 days)
Trial: 31594736
Drug: Maintenance intravesical
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance intravesical chemotherapy (MIC)
Trial: 24570981
Drug: Implants at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implants at least 10 mm long in augmented bone
Trial: 21742400
Drug: Extracorporeal shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shockwave therapy (ESWT), administered twice per week for a total of six treatments.
Trial: 25764643
Drug: Intra-operative periarticular
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-operative periarticular injection with multimodal drugs (diclofenac, adrenaline, marcaine, morphine)
Trial: 1394808
Drug: Intra-arterial administration
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial administration of methotrexate (MTX), Adriamycin (ADM), and cisplatin (CDDP; IA-MAC)
Trial: 6372133
Drug: Combination inhaler
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination inhaler
Trial: 26963600
Drug: Behavior Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior Therapy (BT)
Trial: 26836950
Drug: Quisinostat 12
RxNorm normalized name: Quisinostat
DrugBank: Quisinostat (DB12985)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quisinostat 12 mg three times weekly
Trial: 18758201
Drug: OxyContin tablets
RxNorm normalized name: Oxycontin
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: OxyContin tablets (controlled‐release oxycodone hydrochloride: 5, 10, 20, and 40 mg)
Trial: 18758197
Drug: OxyContin tablets
RxNorm normalized name: Oxycontin
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: OxyContin tablets
Trial: 22414875
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone administration
Trial: 9390588
Drug: Nicardipine 2
RxNorm normalized name: nicardipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 2 mg
Trial: 27098105
Drug: β blockers
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β blockers
Trial: 16919578
Drug: Myocardial oxidative
RxNorm normalized name: Ferrosoferric Oxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myocardial oxidative metabolism (kmono) in NIDCM patients
Trial: 16919578
Drug: Myocardial oxidative
RxNorm normalized name: Ferrosoferric Oxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myocardial oxidative metabolism (kmono) in normal subjects
Trial: 14586387
Drug: Air breathing
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air breathing (7 days, 250 mg chlorzoxazone and 250 mg caffeine)
Trial: 23575256
Drug: Fasting insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fasting insulin levels
Trial: 30778572
Drug: L-OTM
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-OTM
Trial: 25820066
Drug: AVA vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVA vaccine
Trial: 3057688
Drug: Continuous cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous cyclosporine (CsA) therapy
Trial: 27330977
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg risperidone
Trial: 11529540
Drug: Low-dose erythromycin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose erythromycin (2.5 mg kg(‐1) per dose 6 hourly)
Trial: 29936918
Drug: Consistently vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consistently vitamin D sufficient (25(OH)D>50 nmol/l at both months 3 and 24)
Trial: 27384676
Drug: DDGP regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDGP regimen (cisplatin, dexamethasone, gemcitabine, pegaspargase); 6 cycles of chemotherapy
Trial: 2905806
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg lormetazepam
Trial: 6121579
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg flunitrazepam
Trial: 2228036
Drug: NOR 400
RxNorm normalized name: Nor-adrenaline
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NOR 400 mg t.i.d. for 10 days
Trial: 2228036
Drug: NOR 800
RxNorm normalized name: Nor-adrenaline
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NOR 800 mg b.i.d. for 10 days
Trial: 19827462
Drug: Immediate Feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate Feeding (IF): CHO-PRO solution (1.2 g CHO/kg BM and 0.4 g PRO/kg BM) immediately postexercise
Trial: 23537313
Drug: Weekly (W)
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly (W) schedule with gemcitabine 800 mg/m2 Day 1,15 + paclitaxel 80 mg/m2 Day 1,8,15 q4W
Trial: 27910037
Drug: Activated Charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated Charcoal (AC) administered at 8 hours post-dose
Trial: 18945396
Drug: Psychological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatment
Trial: 27055527
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate monotherapy
Trial: 16190795
Drug: Extended-release methylphenidate
RxNorm normalized name: methylphenidate Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release methylphenidate (ER-MPH) 40 mg
Trial: 12481675
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (10 g) with magnesium sulphate and propantheline (15 mg)
Trial: 12481675
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (10 g) with metoclopramide (10 mg)
Trial: 20350147
Drug: Levocetirizine 5
RxNorm normalized name: Levocetirizine 5mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocetirizine 5 mg once daily
Trial: 1898891
Drug: Low-dose human
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose human menopausal gonadotropin (hMG)
Trial: 17265577
Drug: Simplified version
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simplified version of the HIV vaccine process
Trial: 15576836
Drug: 5.6 g
RxNorm normalized name: aspirin 15.6 GM Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.6 g of phosphatidylinositol (PI) with food
Trial: 7486464
Drug: 7-valent pneumococcal-conjugate
RxNorm normalized name: Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
DrugBank: Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal-conjugate vaccine
Trial: 7486464
Drug: HIB-conjugate vaccine
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HIB-conjugate vaccine
Trial: 323297
Drug: Methylprednisolone sodium
RxNorm normalized name: methylPREDNISolone sodium phosphate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone sodium phosphate (40, 80, or 160 mg)
Trial: 20805299
Drug: Saracatinib 175
RxNorm normalized name: Saracatinib
DrugBank: Saracatinib (DB11805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saracatinib 175 mg once daily
Trial: 22178855
Drug: injectable trace
RxNorm normalized name: Trace metal Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: injectable trace mineral supplement (ITM; n = 42; 7 mL subcutaneous; MultiMin, Fort Collins, CO)
Trial: 7781259
Drug: All four
RxNorm normalized name: Jackson's The Original All Fours
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All four treatments (torsemide and furosemide in both oral and intravenous forms)
Trial: 30950637
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment after initial treatment (MSM or BPT)
Trial: 23842127
Drug: sustained HIV-1
RxNorm normalized name: Remune HIV-1
DrugBank: Remune (DB17772)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sustained HIV-1 RNA suppression below 400 copies/ml
Trial: 7808491
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and ticlopidine
Trial: 12454840
Drug: Entecavir 0.5
RxNorm normalized name: entecavir 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entecavir 0.5 mg/day
Trial: 8659784
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ED95 dose of 100 microg/kg mivacurium)
Trial: 22187804
Drug: Oral amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amino acid supplementation
Trial: 20110014
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER 225 mg tablet (study C)
Trial: 20110014
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER 150 mg + 75 mg capsules (study D)